Marc Ferrer Selected Research

Marc Ferrer Research Topics

Disease

47	Neoplasms (Cancer) 01/2022 - 12/2006
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2013
7	Infections 05/2021 - 04/2015
5	Inflammation (Inflammations) 12/2022 - 09/2009
5	ST Elevation Myocardial Infarction 12/2022 - 12/2017
5	Ovarian Neoplasms (Ovarian Cancer) 08/2021 - 01/2017
5	Breast Neoplasms (Breast Cancer) 11/2018 - 12/2003
5	Alzheimer Disease (Alzheimer's Disease) 10/2018 - 05/2005
4	Virus Diseases (Viral Diseases) 01/2022 - 12/2019
4	COVID-19 01/2022 - 06/2020
4	Melanoma (Melanoma, Malignant) 01/2020 - 01/2013
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2020 - 01/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2019 - 01/2018
3	Rhabdomyosarcoma 01/2018 - 01/2017
3	Lysosomal Storage Diseases (Lysosomal Storage Disease) 11/2016 - 01/2011
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2014 - 06/2012
2	Ventricular Fibrillation 12/2022 - 01/2018
2	Neurofibrosarcoma (MPNST) 01/2022 - 07/2020
2	Human Influenza (Influenza) 05/2021 - 01/2019
2	Carcinogenesis 01/2021 - 01/2017
2	Starvation 01/2020 - 03/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 11/2017
2	Rare Diseases (Rare Disease) 01/2019 - 01/2017
2	Disease Progression 01/2019 - 01/2017
2	Substance-Related Disorders (Drug Abuse) 01/2018 - 09/2016
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 12/2017
2	Mood Disorders (Mood Disorder) 04/2017 - 12/2010
2	Fibrosarcoma 11/2016 - 01/2013
2	Neurologic Manifestations (Neurological Manifestations) 11/2016 - 03/2013
2	Globoid Cell Leukodystrophy (Krabbe Disease) 11/2016 - 03/2013
2	Colonic Neoplasms (Colon Cancer) 10/2016 - 11/2008
2	Leukemia 10/2015 - 01/2013
2	Heart Failure 01/2015 - 01/2013
2	Borderline Personality Disorder (Personality Disorders, Borderline) 10/2014 - 03/2012
2	Insulin Resistance 01/2012 - 03/2009
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2010 - 01/2008

Drug/Important Bio-Agent (IBA)

25	Pharmaceutical PreparationsIBA 01/2022 - 06/2008
20	Proteins (Proteins, Gene)FDA Link 12/2022 - 11/2006
6	Antiviral Agents (Antivirals)IBA 01/2022 - 04/2015
5	Drug CombinationsIBA 12/2020 - 10/2012
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2015
4	Phosphotransferases (Kinase)IBA 01/2021 - 08/2014
4	Peptides (Polypeptides)IBA 11/2019 - 05/2005
4	Transcription Factors (Transcription Factor)IBA 01/2018 - 03/2015
3	CytokinesIBA 12/2022 - 09/2009
3	Biological ProductsIBA 08/2021 - 07/2011
3	RelaxinIBA 11/2019 - 01/2013
3	Mitogen-Activated Protein KinasesIBA 01/2018 - 01/2017
3	EnzymesIBA 11/2016 - 06/2008
3	Amyloid (Amyloid Fibrils)IBA 10/2016 - 11/2006
3	Amyloid beta-PeptidesIBA 10/2016 - 05/2005
3	navitoclaxIBA 02/2016 - 01/2013
3	InterferonsIBA 04/2015 - 12/2011
3	Small Interfering RNA (siRNA)IBA 01/2013 - 12/2006
2	NucleosidesIBA 01/2022 - 06/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 11/2018
2	pyrimidineIBA 01/2022 - 06/2021
2	remdesivirIBA 01/2022 - 06/2021
2	LipidsIBA 12/2021 - 01/2020
2	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 08/2015
2	MicroRNAs (MicroRNA)IBA 01/2021 - 12/2018
2	LuciferasesIBA 03/2020 - 01/2013
2	DystrophinIBA 01/2020 - 01/2017
2	AntigensIBA 01/2020 - 12/2016
2	Histones (Histone)IBA 11/2019 - 01/2019
2	Therapeutic UsesIBA 11/2019 - 01/2015
2	Growth Differentiation Factor 15IBA 10/2019 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2019 - 12/2018
2	metarrestinIBA 12/2018 - 01/2018
2	Cocaine (Cocaine HCl)IBA 01/2018 - 04/2017
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018 - 01/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018 - 01/2017
2	trametinibIBA 01/2018 - 01/2018
2	BenzodiazepinesIBA 04/2017 - 12/2010
2	AcidsIBA 01/2017 - 09/2012
2	ChromatinIBA 01/2017 - 11/2008
2	TOR Serine-Threonine KinasesIBA 01/2017 - 03/2015
2	Estrogen Receptor alphaIBA 12/2016 - 12/2003
2	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 06/2012
2	GalactosylceramidaseIBA 11/2016 - 03/2013
2	propylene diquat (PDQ(+))IBA 09/2016 - 03/2012
2	CateninsIBA 05/2016 - 01/2013
2	chlorcyclizineIBA 02/2016 - 04/2015
2	ruxolitinibIBA 02/2016 - 10/2015
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2014 - 01/2013
2	Lysergic Acid Diethylamide (LSD)IBA 09/2012 - 01/2011
2	Insulin (Novolin)FDA Link 01/2012 - 03/2009
2	LipopolysaccharidesIBA 12/2011 - 09/2009
1	ProteomeIBA 12/2022
1	Interleukin-8 (Interleukin 8)IBA 12/2022
1	Interleukin-6 (Interleukin 6)IBA 12/2022
1	pyrrolopyrimidineIBA 01/2022
1	carfilzomibIBA 01/2022
1	PanobinostatIBA 01/2022
1	molnupiravirIBA 01/2022

Therapy/Procedure

31	Therapeutics 01/2022 - 12/2003
8	Drug Therapy (Chemotherapy) 06/2020 - 06/2012
3	Percutaneous Coronary Intervention 01/2019 - 12/2017
2	Immunotherapy 01/2020 - 12/2016
1	Ultrasonic Therapy 01/2022